Q1 FY27 results: Revenue down 17%, PAT Rs 78 cr; QIP raises Rs 800 cr

Revenue declinedResults View source PDF Explain this filing

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.8%Reaction day

₹625.00

prior close

₹579.70

announcement price

In-mkt

timing

Nifty Smallcap 250market+1.4%-7.2% vs market

Pharmaceuticals peers, median of 163sector+1.0%-6.8% vs sector

On the reaction day the stock moved 7.2 pts less than Nifty Smallcap 250 and 6.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.2

10m

+0.2

15m

+2.2

30m

+2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.8+1.4-7.2+1.0-6.8

Next day

-6.7+1.5-8.3+0.8-7.5

-4.8+2.2-7.0+0.3-5.1

-5.9+2.4-8.4+0.7-6.7

-5.1+2.4-7.6+1.5-6.6

-5.3+2.4-7.7+1.3-6.6

-5.9+2.3-8.2+1.6-7.6

15d

-5.4+2.5-8.0+0.9-6.3

-7.5+2.9-10.4+1.7-9.2

-14.8-1.5-13.3+1.9-16.7

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Blue Jet Healthcare Q1 FY27 revenue fell to Rs 293.1 cr from Rs 354.8 cr YoY, about 17% decline. PAT was Rs 78.3 cr vs Rs 91.2 cr. EPS at Rs 4.51. Board re-appointed Executive Chairman and Managing Director for 5 years each, and re-appointed statutory auditors KKC & Associates. After Q1 end, company raised Rs 800 cr via QIP issuing 1.58 cr shares at Rs 506. Dividend of Rs 1.2 per share record date Sept 14, 2026.

Likely market impact

Revenue and profit declined YoY in Q1, but Rs 800 cr QIP strengthens balance sheet. Leadership continuity via director re-appointments.